Ligand Pharmaceuticals Incorporated (LGND) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Ligand (LGND) Q1 2026: Zoma Acquisition to Add 120+ Assets, Lifting Royalty Growth Trajectory
May 07, 2026
-
Ligand (LGND) Q4 2025: Royalty Revenue Jumps 48% as Portfolio Drives $1B Deployable Capital
February 26, 2026
-
Ligand (LGND) Q3 2025: Royalty Revenue Jumps 47% as Portfolio Expansion Drives 5-Year 22% CAGR Outlook
November 06, 2025
-
Ligand (LGND) Q2 2025: Royalty Revenue Surges 57% as Pipeline and Portfolio Expansion Drive Upward Guidance
August 07, 2025
-
Ligand (LGND) Q1 2025: Royalty Revenue Jumps 44%, Pipeline and Special Situations Expand Growth Runway
July 07, 2025